Mark Waddle, MD
Radiation Oncology · Rochester, MNNPI 1275910812
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,005 of the $1,355 with a category attached, or 74.2%. 9 manufacturers reported payments, led by Teleflex LLC at 55.3% of the total.
Across 14 payments — averaging $96.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teleflex LLC$749
- Brainlab, Inc.$234
- Novocure Inc.$146
- E.r. Squibb & Sons, L.L.C.$101
- Astellas Pharma US Inc$31
- Johnson & Johnson$31
- plus $63 from 3 others
Across 4 payments — averaging $55,972 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Siemens Medical Solutions USA, Inc.$133K
- Boston Scientific$91K
What the payments were for
- Speaking & faculty fees$35026%
- Food & beverage$1,00574%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teleflex LLC | 4 | $749 |
| Brainlab, Inc. | 1 | $234 |
| Novocure Inc. | 2 | $146 |
| E.r. Squibb & Sons, L.L.C. | 1 | $101 |
| Astellas Pharma US Inc | 1 | $31 |
| Johnson & Johnson(2 entities) | 2 | $31 |
| Pfizer | 1 | $30 |
| AstraZeneca | 1 | $19 |
| Servier Pharmaceuticals LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,355 in reported general payments places this provider in the 85th percentile of 128 radiation oncology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mometasone Furoate | 15 | $328 |
| Tamsulosin Hcl | 38 | $286 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Rochester
- Aadel ChaudhuriRochester$37K
- Brian DavisRochester$28K
- Jann SarkariaRochester$26K
- Daniel ChamberlainRochester$21K
- Kenneth MerrellRochester$14K
- Meng WelliverRochester$13K
- Tyler WilhiteRochester$5K
- Aurelie GarantRochester$4K
- Sean ParkRochester$4K
- Bryan TraughberRochester$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.